ModivCare Inc. (MODV)
NASDAQ: MODV · Real-Time Price · USD
5.19
-0.23 (-4.24%)
Jan 23, 2025, 4:00 PM EST - Market closed
ModivCare Revenue
ModivCare had revenue of $702.04M in the quarter ending September 30, 2024, with 2.20% growth. This brings the company's revenue in the last twelve months to $2.79B, up 3.16% year-over-year. In the year 2023, ModivCare had annual revenue of $2.75B with 9.85% growth.
Revenue (ttm)
$2.79B
Revenue Growth
+3.16%
P/S Ratio
0.03
Revenue / Employee
$131,491
Employees
21,200
Market Cap
74.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.75B | 246.78M | 9.85% |
| Dec 31, 2022 | 2.50B | 507.50M | 25.41% |
| Dec 31, 2021 | 2.00B | 628.22M | 45.90% |
| Dec 31, 2020 | 1.37B | -141.27M | -9.36% |
| Dec 31, 2019 | 1.51B | 124.98M | 9.02% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 87.70B |
| Merck & Co. | 63.17B |
| AbbVie | 55.53B |
| AstraZeneca | 51.21B |
| Novartis AG | 49.94B |
| Thermo Fisher Scientific | 42.37B |
| Abbott Laboratories | 41.95B |
MODV News
- 13 days ago - Modivcare Raises $105 Million in Incremental Financing Backed by Stakeholders Across the Capital Structure and Takes Strategic Steps to Position Business for the Future - Business Wire
- 5 weeks ago - Top 3 Health Care Stocks That May Explode In Q4 - Benzinga
- 2 months ago - ModivCare, Inc. (MODV) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Modivcare Reports Third Quarter 2024 Financial Results; Affirms 2024 Guidance - Business Wire
- 3 months ago - Modivcare and Tenovi Partner to Advance Respiratory Care, Lower Hospitalizations, and Cut Costs with Adherium's Hailie® Smart Inhalers - Business Wire
- 3 months ago - Modivcare to Report Third Quarter 2024 Financial Results - Business Wire
- 3 months ago - Modivcare Boosts Health Care Experiences with Genesys Cloud AI - Business Wire
- 4 months ago - ModivCare Inc (MODV) Shares Up 25.09% on Oct 2 - GuruFocus